A Study of LCL161 in Combination With Weekly Paclitaxel in Adult Patients With Advanced Solid Tumors
Status:
Completed
Trial end date:
2015-01-01
Target enrollment:
Participant gender:
Summary
This is a dose escalation study that will assess the safety and efficacy of LCL161 in
combination with weekly paclitaxel in adult patients with advanced solid tumors.